2025
Warren Alpert Foundation Prize
Each year the recipient(s) of the Warren Alpert Foundation Prize are recognized at a scientific symposium hosted by Harvard Medical School.
October 30, 2025 2:00 pm to 5:30 pm
2025 Warren Alpert Foundation Prize Symposium
The Warren Alpert Foundation Prize recognizes three scientists for their critical contributions understanding the structure and function of the HIV capsid and to the discovery and development of lenacapavir, the first approved drug to disrupt a viral capsid and whose potency and twice yearly dosing regimen has the potential to significantly accelerate the end of the HIV epidemic.


Tomas Cihlar


John Link


Wesley Sundquist

Join Us
Thursday, October 30th
2:00 pm to 5:30 pm
Joseph B. Martin Conference Center Harvard Medical School 77 Avenue Louis Pasteur
Open to the Public. Seating is on a first come, first served basis.
Symposium Program
Each year the recipient(s) of the Warren Alpert Foundation Prize are recognized at a scientific symposium hosted by Harvard Medical School.
Details to Follow.

Sign up to receive updates

For questions about the prize, please contact us.


This award recognizes the remarkable path from the discovery of the CF gene to the development of therapies that treat the cause of CF. It has been a privilege for me to be part of this journey and I am honored to receive the Alpert Award with such accomplished scientists and physicians as Drs. Collins, Tsui, Welsh and Ramsey. I am also humbled and grateful to represent the amazing team that discovered and brought these medicines to patients. This award is meaningful for all of us because it acknowledges that our work over the past 20 years has had a positive impact on people with CF and their families.
- Paul Negulescu